Bilirubin Levels are Associated With Contrast-Induced Nephropathy in Peripheral Artery Disease

Ertan Vuruşkan1, Erhan Saraçoğlu1

  • 11 Department of Cardiology, Dr Ersin Arslan Education and Research Hospital, Gaziantep, Turkey.

Angiology
|November 18, 2016
PubMed

Insights

Low serum bilirubin levels are linked to contrast-induced nephropathy (CIN) in peripheral artery disease (PAD) patients. This finding highlights bilirubin

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Contrast-induced nephropathy (CIN) is a significant complication following radiocontrast administration.
  • Oxidative stress is implicated in CIN pathogenesis.
  • Serum bilirubin's antioxidant properties suggest a potential role in mitigating CIN.

Purpose of the Study:

  • To investigate the association between serum total bilirubin levels and the development of CIN in patients with peripheral artery disease (PAD).
  • To evaluate serum bilirubin as a potential biomarker for predicting CIN risk.

Main Methods:

  • Retrospective study of 359 patients with PAD undergoing peripheral diagnostic angiography.
  • Comparison of 179 patients who developed CIN with 180 matched control patients.
  • Analysis of baseline and follow-up laboratory values, including total bilirubin, uric acid, and neutrophil-to-lymphocyte ratio (NLR).

Main Results:

  • Patients who developed CIN had significantly lower baseline total bilirubin levels compared to controls (P < .05).
  • Higher uric acid, red cell distribution width, and NLR were also associated with CIN.
  • Multivariate analysis identified decreased total bilirubin, diabetes mellitus, reduced left ventricular ejection fraction, elevated uric acid, and increased NLR as independent predictors of CIN.

Conclusions:

  • Decreased serum total bilirubin is associated with an increased risk of developing CIN in PAD patients.
  • Serum bilirubin may serve as a valuable antioxidant biomarker for predicting CIN.
  • Further research is warranted to explore therapeutic strategies targeting bilirubin levels to prevent CIN.

Related Concept Videos

Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
438
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
564
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
437